Neutrophil gelatinase-associated lipocalin in contrast-induced acute kidney injury post cardiac procedure: a systematic review
- 24 March 2026
- journal article
- review article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 588, 120977
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Urinary neutrophil gelatinase‐associated lipocalin predicted to contrast‐associated acute kidney injury after planned percutaneous coronary intervention in elderly patientsJournal of Clinical Laboratory Analysis, 2022
- Neutrophil gelatinase-associated lipocalin (NGAL) in kidney injury – A systematic reviewClinica Chimica Acta, 2022
- Tissue inhibitor metalloproteinase 2 (TIMP-2) and insulin-like growth factor binding protein 7 (IGFBP7) best predicts the development of acute kidney injuryHeliyon, 2021
- The global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patientsJournal Of Nephrology, 2021
- Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy StudiesJAMA, 2018
- Contrast-Induced Acute Kidney InjuryJACC, 2016
- Serum neutrophil gelatinase associated lipocalin (NGAL) and cystatin C as early predictors of contrast-induced acute kidney injury in patients undergoing percutaneous coronary interventionClinica Chimica Acta, 2014
- Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelinesEuropean Radiology, 2011
- Prevention, Incidence, and Outcomes of Contrast-Induced Acute Kidney InjuryArchives of internal medicine (1960), 2008
- Epidemiology and Prognostic Implications of Contrast-Induced NephropathyThe American Journal of Cardiology, 2006